Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1993 Aug;46(8):778–779. doi: 10.1136/jcp.46.8.778

Rearrangements of c-myc and c-abl genes in tumour cells in Burkitt's lymphoma.

S Casares 1, J M Rodríguez 1, A Martin 1, A Parrado 1
PMCID: PMC501473  PMID: 8408711

Abstract

Rearrangements of oncogenes c-myc and c-abl were detected by non-radioactive hybridisation in a case of Burkitt's lymphoma/leukaemia. The surface phenotype of Burkitt's cells were positive for CD19, CD20, HLA-DR, CD14, CD33 and surface immunoglobulin markers. Although cytogenetic analysis was not performed, the c-myc and heavy immunoglobulin genes had the same 14.2 kilobase EcoRI molecular size fragment, suggesting a possible t(8;14) translocation which is a common marker of this malignancy. The c-abl oncogene was also rearranged in DNA digested BamHI and EcoRI. The physiopathological implications of the rearranged c-abl gene are unknown, this being the first case, as for as is known, of Burkitt's lymphoma/leukaemia with a rearranged c-abl gene.

Full text

PDF
778

Images in this article

779Image
on p.779
779Image
on p.779

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. De Jong D., Voetdijk B. M., Beverstock G. C., van Ommen G. J., Willemze R., Kluin P. M. Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma. N Engl J Med. 1988 May 26;318(21):1373–1378. doi: 10.1056/NEJM198805263182106. [DOI] [PubMed] [Google Scholar]
  2. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983 Jul 1;132(1):6–13. doi: 10.1016/0003-2697(83)90418-9. [DOI] [PubMed] [Google Scholar]
  3. Gauwerky C. E., Hoxie J., Nowell P. C., Croce C. M. Pre-B-cell leukemia with a t(8; 14) and a t(14; 18) translocation is preceded by follicular lymphoma. Oncogene. 1988 May;2(5):431–435. [PubMed] [Google Scholar]
  4. Gauwerky C. E., Huebner K., Isobe M., Nowell P. C., Croce C. M. Activation of MYC in a masked t(8;17) translocation results in an aggressive B-cell leukemia. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8867–8871. doi: 10.1073/pnas.86.22.8867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Groffen J., Stephenson J. R., Heisterkamp N., de Klein A., Bartram C. R., Grosveld G. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell. 1984 Jan;36(1):93–99. doi: 10.1016/0092-8674(84)90077-1. [DOI] [PubMed] [Google Scholar]
  6. Lee J. T., Innes D. J., Jr, Williams M. E. Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma. J Clin Invest. 1989 Nov;84(5):1454–1459. doi: 10.1172/JCI114320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. McCarthy D. M., Rassool F. V., Goldman J. M., Graham S. V., Birnie G. D. Genomic alterations involving the c-myc proto-oncogene locus during the evolution of a case of chronic granulocytic leukaemia. Lancet. 1984 Dec 15;2(8416):1362–1365. doi: 10.1016/s0140-6736(84)92058-0. [DOI] [PubMed] [Google Scholar]
  8. NOWELL P. C., HUNGERFORD D. A. Chromosome studies on normal and leukemic human leukocytes. J Natl Cancer Inst. 1960 Jul;25:85–109. [PubMed] [Google Scholar]
  9. Saito H., Hayday A. C., Wiman K., Hayward W. S., Tonegawa S. Activation of the c-myc gene by translocation: a model for translational control. Proc Natl Acad Sci U S A. 1983 Dec;80(24):7476–7480. doi: 10.1073/pnas.80.24.7476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Stass S. A., Mirro J., Jr Lineage heterogeneity in acute leukaemia: acute mixed-lineage leukaemia and lineage switch. Clin Haematol. 1986 Aug;15(3):811–827. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES